PDS Biotechnology Statistics
NASDAQ: PDSBHealth CareBiotechnology: Pharmaceutical PreparationsUSD
0.7774-0.0299 (-3.70%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
PDS Biotechnology by the numbers
PDS Biotechnology has a market capitalization of $95.4 million based on 122.70M shares outstanding. With trailing EPS of $-0.54, PDS Biotechnology is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 25.4% below its 50-day average and 7.7% below its 200-day average.
Average daily trading volume is 25.64M shares, or about $19.9 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
PDSB valuation vs. peer median
| Metric | PDSB | Peer median | Difference |
|---|---|---|---|
| Market cap | $95.39M | $95.79M | -0% |
| Avg. volume | 25.64M | 639.64K | +3908% |
Peer median across 8 companies: NRXP, NBP, DERM, UNCY, CLLS, CNTN, NERV, CATX.
Valuation
- Market cap
- $95.39M
- EPS (TTM)
- $-0.54
- Shares outstanding
- 122.70M
Price and trading
- Previous close
- 0.8073
- Open
- 0.80
- Day range
- 0.7703 – 0.8451
- 52-week range
- 0.195 – 1.79
- 52-week change
- +2.97%
- 200-day moving average
- 0.8422
- Beta
- —
- Volume
- 2.89M
- Average volume
- 25.64M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 13, 2026
Additional statistics
- Market Cap
- 95.39M
- Forward Pe
- -5.98
- Eps
- -0.54
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 1.79
- Week52 Low
- 0.20
- Avg Volume
- 25.64M
- Shares Outstanding
- 122.70M
- Ma50
- 1.04
- Ma200
- 0.84
- Earnings Date
- Nov 13, 2026
- Pct From52w High
- -56.57%
- Pct From52w Low
- 298.67%